Cheapest tirzepatide injection plans: offers beyond the lowest monthly number
Tirzepatide offers may be discounted for the first supply, quoted as an annual equivalent or presented as a month-to-month bundle. The smallest printed figure can th
Article updated
Read this firstArticle updated November 13, 2026; source dates below
Use tirzepatide-specific terms, rather than applying another medicine’s advertised minimum.
CoreAge Rx
$129/mo promo
CoreAge tirzepatide promotion; separate product-page terms were not refreshed.
SuperHealthy Rx
$135/mo promo
Tirzepatide on the dedicated promotion.
Likeness Rx
$129/mo equivalent
Annual tirzepatide term is $1,548; monthly option is $199.
Tirzepatide offers may be discounted for the first supply, quoted as an annual equivalent or presented as a month-to-month bundle. The smallest printed figure can therefore require the largest initial payment. These seven named routes make those conditions part of the comparison.
Injection Index compares compounded tirzepatide offers separately from branded Zepbound. The ingredient name does not make the products equivalent or establish FDA approval of a compound. The purpose is to understand the selected offer, not to identify a clinically superior medicine or a universally cheapest provider.
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
GLP-1 plus GIP offer; confirm actual compounded preparation and terms
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
Likeness and Trimi publish annual and shorter-term structures, while other promotions describe a starting monthly figure. An annual equivalent and a month-to-month payment are different commitments. The chart preserves that distinction and does not claim that each offer supplies an identical preparation.
Ask what happens to price when the prescribed amount changes, whether the medicine and clinical service are included, and how an early medical stop is handled. Those answers can matter more to the actual cost than a small difference between advertised minima.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
Use tirzepatide-specific terms, rather than applying another medicine’s advertised minimum. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Cheapest tirzepatide injection plans: offers beyond the lowest monthly number — compare what the payment covers, when it renews and which charges remain separate.
What makes this shortlist useful
Keep the actual preparation, quantity and supply period visible. Compare the initial charge and ordinary renewal, then ask what payment term qualifies for a promotion. An annual plan should show the full advance bill, and a four-week refill should not be called a calendar month. Clinical access, supplies and shipping belong in the complete quotation. Read the related care guide for a wider treatment discussion.
What makes this shortlist useful — keep the exact product identity and its complete label together.
1. CoreAge Rx: the tirzepatide-specific monthly offer
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. Use the tirzepatide product’s rate rather than the lower semaglutide price. The no-membership structure can simplify one line of the bill, while dispensed amount and the reason for compounding remain separate questions.
CoreAge’s linked promotion advertises compounded semaglutide at $79 per month and tirzepatide at $129. Read the dated CoreAge Rx update before using a main-product price; retain the selected offer and confirm the commitment and amount due. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Read the SuperHealthy Rx review.
SuperHealthy Rx: compare the selected agreement with the questions in this section.
3. Likeness Rx — GLP-1 weight care
Read the preparation and recurring invoice together. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. SnagRx: a tirzepatide promotion to qualify
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. The tirzepatide promotion has its own amount and term conditions. Confirm the selected supply and later invoice, and do not assume a cancellation headline means an already prepared or purchased order can be refunded.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
SnagRx: compare the selected agreement with the questions in this section.
5. AltRx: a GLP-1 plus GIP offer
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. The higher GLP-1 plus GIP card should be used for this comparison, with the actual ingredient and preparation confirmed. A lower GLP-1 headline belongs to a different offer and should not be carried into a tirzepatide list.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
6. Enhance.MD: introductory and continuing tirzepatide prices
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. The page explicitly separates the first tirzepatide payment from the later four-week price. Retaining both prevents an apparently cheap introduction from becoming an understated ongoing treatment budget.
The dated Enhance.MD update records the observed introductory and continuing cards and their supply period. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
7. Trimi: a lower annual equivalent with upfront cost
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. The annual tirzepatide equivalent is tied to a twelve-month commitment and $1,500 advance bill. It should be compared with the separately quoted month-to-month plan, not presented as a $125 monthly checkout.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Choose the next step, then confirm the order
Ask for the exact tirzepatide preparation and full supply-period quotation. A price-first comparison should still retain the prescription rationale and cancellation terms. If a figure lacks quantity, renewal or qualifying commitment, it is a quote to clarify rather than proof of the cheapest complete order.
Branded tirzepatide evidence does not validate every compounded preparation. FDA recommends considering approved options and explaining the individual need for compounding. Treatment choice, concentration and dose should come from the clinician and pharmacy label rather than a price table.
Original references are retained below. Later observations and their source dates are identified in the dated updates and research notes. Advertising describes an offer; it is not independent verification of treatment outcomes.